Search research articles
Contact Us
Filters
Showing results (271-280 of 672) with videos related to
Page
of 68
Sort By:
Prostaglandins
|
January 1, 1991
Enhanced mitotic activity induced by irradiation is abolished by PGI2 pretreatment
H Sinzinger, T Zidek, F Rauscha, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1987
Interaction between the platelet derived growth factor and prostaglandin I2 is important for atherosclerosis
H Sinzinger, G Steurer, J Kaliman, et al.
Folia Haematologica (Leipzig, Germany : 1928)
|
January 1, 1988
In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins
P Fitscha, J Kaliman, J O'Grady, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Beneficial effect of prostaglandin I2 on smooth muscle cell proliferation
T Zidek, G Steurer, P Fitscha, et al.
Pharmacological Research Communications
|
October 1, 1982
The effect of clofibrate on plasma factor and vascular prostacyclin-synthesis
E Jäger, A Kefalides, P Clopath, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
The intrainfusion rebound platelet activation during continuous prostaglandin I2 infusion occurs at the receptor level
H Sinzinger, G Steurer, P Fitscha, et al.
Acta Anatomica
|
January 1, 1990
Esophageal prostaglandins in guinea pigs and rats
S Aharinejad, P Franz, H Sinzinger, et al.
Atherosclerosis
|
November 1, 1979
Prostacyclin synthesis in human and experimental atherosclerosis
H Sinzinger, P Clopath, K Silberbauer, et al.
Acta Morphologica Neerlando-Scandinavica
|
March 1, 1973
[Possibilities of exactly determining the course of arteries]
L Reisinger, H Sinzinger, W Feigl, et al.
Thrombosis Research
|
October 23, 1997
Hyperalphalipoproteinemia and prostaglandin I2 stability
C Pirich, Y Efthimiou, J O'Grady, et al.
Page
of 68
Search research articles
Search
Showing results (271-280 of 672) with videos related to
Sort By:
Page
of 68
Prostaglandins
|
January 1, 1991
Enhanced mitotic activity induced by irradiation is abolished by PGI2 pretreatment
H Sinzinger, T Zidek, F Rauscha, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1987
Interaction between the platelet derived growth factor and prostaglandin I2 is important for atherosclerosis
H Sinzinger, G Steurer, J Kaliman, et al.
Folia Haematologica (Leipzig, Germany : 1928)
|
January 1, 1988
In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins
P Fitscha, J Kaliman, J O'Grady, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Beneficial effect of prostaglandin I2 on smooth muscle cell proliferation
T Zidek, G Steurer, P Fitscha, et al.
Pharmacological Research Communications
|
October 1, 1982
The effect of clofibrate on plasma factor and vascular prostacyclin-synthesis
E Jäger, A Kefalides, P Clopath, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
The intrainfusion rebound platelet activation during continuous prostaglandin I2 infusion occurs at the receptor level
H Sinzinger, G Steurer, P Fitscha, et al.
Acta Anatomica
|
January 1, 1990
Esophageal prostaglandins in guinea pigs and rats
S Aharinejad, P Franz, H Sinzinger, et al.
Atherosclerosis
|
November 1, 1979
Prostacyclin synthesis in human and experimental atherosclerosis
H Sinzinger, P Clopath, K Silberbauer, et al.
Acta Morphologica Neerlando-Scandinavica
|
March 1, 1973
[Possibilities of exactly determining the course of arteries]
L Reisinger, H Sinzinger, W Feigl, et al.
Thrombosis Research
|
October 23, 1997
Hyperalphalipoproteinemia and prostaglandin I2 stability
C Pirich, Y Efthimiou, J O'Grady, et al.
Page
of 68